Grants & Funding Opportunities

As part of ACCP's ongoing commitment to Members, we will routinely post appropriately aligned Grants & Funding Opportunities from a variety of sources. Information will be updated in a timely manner and we encourage Members to visit this link frequently for up-to-date information on valuable funding sources. Members are welcome to recommend additional links for posting by forwarding the information to

Alzheimer's Drug Discovery Foundation Invites Letters of Intent for Biomarker Trials

The Alzheimer's Drug Discovery Foundation and the Alzheimer's Disease Cooperative Study are collaborating to support pilot biomarker-based clinical trials of novel therapeutics for Alzheimer’s disease.

Through this grant initiative, ADDF and ADCS will provide funding and resources to one or more clinical trials. Priority will be given for therapeutics whose target engagement can be directly assessed in humans using serial cerebrospinal fluid sampling. In addition to funding, ADCS will contribute resources and infrastructure for data management, quality control, and statistics support. ADCS also will offer access to unique biomarker assays including the SILK technology, if appropriate.

POSTED: July 20, 2014
DEADLINE: August 22, 2014 (Letters of Intent)

Alliance for Lupus Research Accepting Letters of Intent for Research Projects

Grants of up to $600,000 over three years will be awarded for research that accelerates the development of new treatments for lupus. Funded projects will include fundamental studies in genetics, immunology, cell biology, and molecular biology that identify and characterize molecular systems for the purpose of developing drugs that can prevent and/or ameliorate clinical signs and symptoms of lupus. ALR particularly welcomes proposals for research that applies knowledge gained in other disease areas (e.g., cancer, metabolic diseases) to mechanisms relevant to lupus.

Individuals with a doctoral degree (M.D., Ph.D., or equivalent) are eligible to apply. Applicants must demonstrate scientific independence by presenting evidence of having directed a research program, a publication record, or other experience that establishes scientific leadership.

Deadline Letters of intent: July 10, 2014.
Upon review, selected applicants will be invited to submit a complete proposal by August 25.

Immune Tolerance Network Issues RFP for Trials of Transplantation Therapies

The Immune Tolerance Network is an international clinical research consortium founded by the National Institute of Allergy and Infectious Disease. ITN develops, implements, and conducts trials of novel immune tolerance therapeutics for Type 1 Diabetes, autoimmune diseases, transplantation, and allergy and asthma.

To support this mission, the network has issued a Request for Proposals for clinical tolerance trials in transplantation using solid organs or islets from deceased donors. Preference will be given to trials with a testable mechanism of tolerance induction and a strategy for assays investigating this mechanism. ITN is particularly interested in proposals for phase II trials that involve between five and thirty patients.

POSTED: July 23, 2014
DEADLINE: August 29, 2014 (Letters of Inquiry)

World Federation of Hemophilia Accepting LOIs for Clinical Research Grant Program

The World Federation of Hemophilia is accepting Letters of Intent for international clinical research projects relating to inherited bleeding disorders.

Through its Clinical Research Grant Program, WFH will award grants of up to $50,000 to support investigations designed to create better evidence for the clinical management of hemophilia A and B, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders.

POSTED: July 20, 2014
DEADLINE: August 31, 2014 (Letters of Intent)

American Optometric Foundation Seeks Applications for Glaucoma Research Projects

The American Optometric Foundation, the charitable arm of the American Academy of Optometry, is inviting applications for research projects related to glaucoma and the anterior segment.

Through the Allergan Foundation Research Grant program, one $60,000 grant will be awarded to support talented optometry and vision science faculty and investigators in innovative research in the area of glaucoma or the anterior segment. In addition, a $750 travel grant will be provided for the principal investigator and up to three co-investigators on the project to attend Academy 2015 New Orleans, the annual conference of the AAO.

POSTED: July 24, 2014
DEADLINE: September 1, 2014

ARVO Foundation Invites Applications for Genentech Age-Related Macular Degeneration Research Fellowships

The ARVO Foundation for Eye Research, the philanthropic arm of the Association of Research in Vision and Ophthalmology, is inviting applications for two Genentech Age-Related Macular Degeneration Research Fellowships to support research about age-related macular degeneration. One $40,000 grant will be awarded to a researcher working in basic research in the understanding of AMD and another $40,000 grant will be awarded to a researcher working in translational AMD research focusing on therapeutics.

POSTED: July 22, 2014
DEADLINE: September 30, 2014

Angelman Syndrome Foundation Announces $1 Million RFP for AS Research

The Angelman Syndrome Foundation's mission is to advance the awareness and treatment of Angelman syndrome through education and information, research, and support for individuals with AS, their families, and other concerned parties. To date, the foundation has invested more than $6 million in AS research, supporting seventy-eight projects worldwide.

ASF has issued a $1 million Request for Proposals for new AS-related research projects. One- or two-year grants of up to $100,000 per year will be awarded to promising preclinical, translational, or clinical research projects that investigate any aspect of AS. Priority will be given to pilot projects to test new ideas about AS pathogenesis and therapeutics.

POSTED: July 26, 2014
DEADLINE: October 15, 2014

Michael J. Fox Foundation for Parkinson's Research Invites Proposals for Target Pipeline Program

The Michael J. Fox Foundation for Parkinson's Research, which seeks to stimulate development of Parkinson's disease therapeutics, is accepting pre-proposals for the spring cycle of its Target Validation program.

Part of the foundation’s annual Edmond J. Safra Core Programs for PD Research, the Target Validation program supports work seeking to determine whether manipulating a novel biological target has impact in a Parkinson’s disease-relevant animal model -- an essential early step to the development of potentially promising therapies.

The program supports two-year grants of up to $250,000. Total annual direct costs cannot exceed $100,000, and no more than 2 percent (academic institutions) or 10 percent (for-profit organizations) may go to indirect costs.

POSTED: July 6, 2014
DEADLINE: October 29, 2014 (Pre-proposals)

Grant funding opportunities at the National Institutes of Health can be found at To Subscribe to the NIH Guide LISTSERV, send an e-mail to with the following text in the message body (not the "Subject" line):
subscribe NIHTOC-L your name
(Example: subscribe NIHTOC-L Bill Jones)

Your e-mail address will be automatically obtained from the e-mail message and add you to the LISTSERV.

Grant opportunities from the Substance Abuse and Mental Health Administration: provides information on funding opportunities across all US Federal agencies:

Grant opportunities from the Alzheimer's Drug Discovery Foundation:

CenterWatch offers several easy-to-search resources on drugs in various stages of development and approval:

21750 Red Rum Drive, Suite 137, Ashburn, VA  20147    Mailing address: PO Box 1758, Ashburn, VA  20146
571-291-3493     Fax: 571-918-4167     Contact Us
Home     About ACCP     Member Login     Healthcare Professionals
Continuing Education     Meetings     Publications     Public Policy     Student Outreach

Site Map | Site contents © 2014 ACCP